S2A : Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals

First Page		Document Content
Date: 2013-07-12 14:26:10 Health Micronucleus test Pharmaceuticals policy Regulatory requirement Mutagen Micronucleus Food and Drug Administration Mutation Biology Pharmaceutical sciences		S2A : Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals Add to Reading List Source URL: www.hc-sc.gc.ca Download Document from Source Website File Size: 50,49 KB Share Document on Facebook

	Automated Scoring of In Vitro Micronucleus Assay The cytokinesis-block micronucleus assay using isolated human lymphocytes serves as a reliable genotoxicity test for evaluation of DNA damage. Workflow DocID: 1utxC - View Document
	6th IWGT Iguassu, Brazil Liver Micronucleus Test (LMNT) Subgroup   DocID: 1gswW - View Document
	The Follow-up Study of Chromosomal aberrations in Chernobyl Clean-up Workers Natalia M. SLOZINA and Elizaveta G. NERONOVA All-Russian Center of Emergency and Radiation Medicine, EMERCOM of Russia, Lebedeva 4/2, 194044, S DocID: 18RPB - View Document
	Chromosomal Aberrations in Blood Lymphocytes of the Residents of 30-km Chornobyl NPP Exclusion Zone Larysa BEZDROBNA, Tetyana TSYGANOK, Olena ROMANOVA, Larysa TARASENKO, Volodymyr TRYSHYN, Ludmila KLIMKINA Institute for DocID: 189ee - View Document
	OECD QSAR Toolbox Version 3.1 Strategies for grouping chemicals to fill data gaps to assess genetic toxicity and genotoxic carcinogenicity (where covalent DNA binding is the molecular initiating event) DocID: 11sB3 - View Document